Enable JavaScript to visit this website.
Skip directly to content

Pfizer Canada Statement: Alesse 21 and Alesse 28 Product Complaints – Update to Health Canada Advisory


KIRKLAND (Quebec) – December 8, 2017 – Pfizer Canada is issuing a communication to health care professionals to provide clear instructions on the importance of examining pills and what to do in case of a missed or partial dose.  Affected pills are those which are broken or split. If patients have questions or concerns about their birth control product, they should talk to their health care professional.

Pfizer is committed to ensuring the safety and quality of our medicines.  Every complaint received by the organization is investigated and, when available, complaint samples are retrieved and analyzed. Pfizer takes patient safety very seriously and takes action if patient safety is at risk.

For more information:
Questions of a medical nature should be referred to Medical Information at 1-800-463-6001 weekdays between 9:00 a.m. and 5:00 p.m. EST

Questions from wholesalers, chains and banners should be directed to Pfizer’s Customer Service Group at 1-800-387-4974.
Pfizer Canada Media Line: 1-866-9Pfizer (1 866 973-4937)
[email protected]